News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski
Jun 28, 2024, 12:53

Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski

Robert Orlowski shared a post on X:

“Myeloma Paper of the Day: A deep learning model trained on whole body low dose CT scans may be able to predict the presence of cytogenetic abnormalities used for high risk stratification in myeloma: ”

Source: Robert Orlowski/X

Whole-body low-dose computed tomography in patients with newly diagnosed multiple myeloma predicts cytogenetic risk: a deep learning radiogenomics study

Authors: Shahriar Faghani, Mana Moassefi, Udit Yadav, Francis K. Buadi, Shaji K. Kumar, Bradley J. Erickson, Wilson I. Gonsalves and Francis I. Baffour.

Myeloma Paper of the Day, June 28th, suggested by Robert Orlowski

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.

Bradley J. Erickson cancer cytogenetic abnormalities Francis I. Baffour Francis K. Buadi high risk stratification low dose CT scans Mana Moassefi MD Anderson Cancer Center Myeloma Myeloma Paper of the Day newly diagnosed multiple myeloma OncoDaily Oncology radiogenomics study Robert Orlowski Shahriar Faghani Shaji K. Kumar Udit Yadav Wilson I. Gonsalves
Special Coverage
Blog
Dec 19, 2024, 02:54
Bladder-Sparing Strategies for MIBC: Insights from Professor Ming Cao at ESMO Asia2024
Blog
Dec 19, 2024, 02:52
Vicki Kennedy: The critical importance of psychosocial oncology standards
Blog
Dec 19, 2024, 02:47
Liver cancer treatment through radioembolization - IMAGIO
Blog
Dec 19, 2024, 02:43
Paolo Tarantino: The highly awaited Breast Cancer trials with positive results
Blog
Dec 19, 2024, 02:34
Javier Muñoz Carrillo: First-hand presentation of cutting-edge clinical trial results in breast cancer research at SABCS24
Science
Dec 19, 2024, 02:31
Laura Bukavina: Use of Perioperative Immunotherapy and TKI in RCC with IVC thrombus patients by Kotaro Suzuki et al.
Science
Dec 19, 2024, 02:26
Nicholas Hornstein: CtDNA for Appendiceal Adenocarcinoma is not as robust as in Colorectal Cancer
Blog
Dec 19, 2024, 02:20
Sathgen Therapeutics Named Company of the Year 2024 by Silicon India Magazine
Blog
Dec 19, 2024, 02:19
Cancer costs the average patient in Canada nearly $33,000 in their lifetime - Canadian Cancer Society
Blog
Dec 19, 2024, 02:17
Living with Blood Cancer makes time precious and more urgent - The Leukemia and Lymphoma Society
Blog
Dec 19, 2024, 02:16
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research - NCI Division of Cancer Prevention
Blog
Dec 19, 2024, 02:11
An upcoming FDA-AACR workshop on DPD deficiency testing